Feb. 13, 2026
New Study Finds No Link Between Prenatal COVID Vaccination and Autism
Research provides additional reassurance that COVID-19 vaccination during pregnancy does not increase risk of neurodevelopmental issues in children.
Feb. 13, 2026
Texas AG Backs Doctor Disciplined for Prescribing Ivermectin
Ken Paxton intervenes in lawsuit against Texas Medical Board over reprimand of Dr. Mary Talley Bowden
Feb. 12, 2026
RFK Jr.'s Promises to Restore Trust in U.S. Health Agencies Faltering
One year after taking over HHS, Kennedy's actions have eroded public confidence, experts warn.
Feb. 12, 2026
New Research Offers Hope for Tackling Long COVID's Economic Toll
Breakthroughs in understanding the biology of Long COVID could lead to more effective treatments and interventions.
Feb. 12, 2026
AMA and VIP to Review Vaccine Evidence
The two organizations say they are doing what CDC's ACIP has failed to do.
Feb. 12, 2026
FDA Official Prasad Faces Allegations Amid Moderna Vaccine Dispute
Vinay Prasad, head of the FDA's biologics division, is accused of misconduct as he rejects Moderna's influenza vaccine application.
Feb. 12, 2026
HHS Casts Doubts On mRNA Products, Funds Studies On Debunked Theories
The agency refuses to review Moderna's application for an mRNA-based flu vaccine while prioritizing research on unproven ideas.
Feb. 12, 2026
Wilco's Jeff Tweedy Grapples with Anxiety and Viral Fear
The alt-rock musician's pandemic response reflects the concerns of many anxious Americans, but his stance on censorship raises questions.
Feb. 11, 2026
AMA to Independently Review Vaccine Safety and Efficacy
Move comes amid federal rollback and erosion of public trust in science
Feb. 11, 2026
WHO Calls on US to Share COVID-19 Origin Intel
The global health agency urges transparency despite US withdrawal from the organization.
Feb. 11, 2026
HHS Developing AI Tool to Monitor Vaccine Side Effects
FDA Official Investigated for Alleged Fake Divorce; Texas Issues Guidance on Abortion Law
Feb. 11, 2026
Moderna's New mRNA Flu Vaccine Rejected by FDA
Agency cites concerns over clinical trial design in 'refusal-to-file' letter to the company.
Feb. 11, 2026
Bioxytran Reports Positive Phase 2 Results for ProLectin-M Antiviral
Rapid viral clearance demonstrated in 100% of patients by day 7 versus placebo
Feb. 11, 2026
Trials Begin for Nasal Spray to Reduce COVID-19, Flu Infections
University of Maryland School of Medicine studying new approach to respiratory illness prevention
Feb. 11, 2026
Wheeling Officials Detect High Levels of COVID-19, RSV, Flu A in Wastewater
Norovirus, Rotavirus, and Human Adenovirus also found in recent testing
Feb. 10, 2026
FDA Refuses Moderna's Application for New mRNA Flu Vaccine
Moderna says the agency objected to how it conducted a key clinical trial for the vaccine.
